Increased pro-inflammatory cytokines (TNF-α and IL-6) and anti-inflammatory compounds (sTNFRp55 and sTNFRp75) in Brazilian patients during exanthematic dengue fever

被引:48
作者
Pinto, LMO
Oliveira, SA
Braga, ELA
Nogueira, RMR
Kubelka, CF
机构
[1] Inst Oswaldo Cruz, Dept Virol, BR-21045900 Rio De Janeiro, Brazil
[2] UFF, HUAP, Disciplina Doencas Infecto Parasitarias, Niteroi, RJ, Brazil
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 1999年 / 94卷 / 03期
关键词
dengue; tumor necrotis factor alpha; interleukin; 6; soluble tumor necrosis; factor receptor;
D O I
10.1590/S0074-02761999000300019
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Pro-inflammatory cytokines, tumor necrosis factor (TNF-alpha), interleukin-6 (IL-6) and interleukin-1 beta (IL-1 beta) as well as anti-inflammatory compounds, soluble TNF-Receptor p55 (sTNFRp55), sTNFRp75 and IL-1 receptor antagonist (sIL-1Ra), were investigated in 34 Brazilian cases of dengue fever (DF) originated from a study of exanthematic virosis. The presence of pro-inflammatory cytokines was detected in sera from these patients by ELISA. TNF-alpha and IL-6 levels were significantly higher than control subjects in 32% and 52% patients, respectively. To our knowledge this was the first time a receptor antagonist and soluble receptors for cytokines were detected in sera obtained during exanthematic DF without hemorrhagic manifestations. Both sTNFRp55 and sTNFRp 75 were consistently elevated in 42% and 84% patients, respectively. Most patients had IL-1 beta levels not different from those of normal subjects, except for one case. Only 16% patients had altered levels of IL-1Ra. Previous studies in dengue hemorrhagic fever patients demonstrated production of these soluble factors; here we observed that they are found in absence of hemorrhagic manifestations. The possible role of these anti-inflammatory compounds in immune cell activation and in regulating cytokine-mediated pathogenesis during dengue infection is discussed.
引用
收藏
页码:387 / 394
页数:8
相关论文
共 43 条
[1]   Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes [J].
Anderson, R ;
Wang, SL ;
Osiowy, C ;
Issekutz, AC .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4226-4232
[2]   HIGH-CONCENTRATIONS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN ASCITES [J].
ANDUS, T ;
GROSS, V ;
HOLSTEGE, A ;
OTT, M ;
WEBER, M ;
DAVID, M ;
GALLATI, H ;
GEROK, W ;
SCHOLMERICH, J .
HEPATOLOGY, 1992, 16 (03) :749-755
[3]  
[Anonymous], 1991, REV MED VIROLOGY, DOI DOI 10.1002/rmv.1980010405
[4]   Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever [J].
Bethell, DB ;
Flobbe, K ;
Phuong, CXT ;
Day, NPJ ;
Phuong, PT ;
Buurman, WA ;
Cardosa, MJ ;
White, NJ ;
Kwiatkowski, D .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :778-782
[5]  
BROWN F, 1984, INTERVIROLOGY, V25, P141
[6]   TECHNIQUES FOR HEMAGGLUTINATION AND HEMAGGLUTINATION-INHIBITION WITH ARTHROPOD-BORNE VIRUSES [J].
CLARKE, DH ;
CASALS, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1958, 7 (05) :561-573
[7]   ROLE OF INTERLEUKIN-1 IN INFECTIOUS-DISEASES [J].
DINARELLO, CA .
IMMUNOLOGICAL REVIEWS, 1992, 127 :119-146
[8]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[9]  
DINARELLO CA, 1996, PATHOLOGY SEPTIC SHO, P134
[10]   DENGUE AND DENGUE HEMORRHAGIC-FEVER [J].
HALSTEAD, SB .
CURRENT OPINION IN INFECTIOUS DISEASES, 1990, 3 (03) :434-438